A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation

It has been suggested that adenosine monophosphate-activated protein kinase (AMPK) and 12 AMPK-related kinases (ARK), including novel (nua) kinase family 1 (NUAK1), are activated by master kinase LKB1, a major tumor suppressor. Apart from evidence to suggest that NUAK1 participates in induction of tumor survival, invasion and p53-independent cellular senescence, its detailed biological functions remain unclear. Here we showed that in the presence of wild-type LKB1, NUAK1 directly interacts with and phosphorylates p53 in vitro and in vivo. The phosphorylation of p53 induced by LKB1 required the kinase activity of NUAK1 and phosphorylation of NUAK1 at Thr211 by LKB1 was essential for its kinase activity, which leads to the conclusion that LKB1 activates NUAK1 and regulates phosphorylation of p53 through the NUAK1 kinase, at least partially. LKB1/NUAK1 activation leads to cell cycle arrest at the G1/S border by inducing expression of p21/WAF1. Under the regulation of LKB1, NUAK1 interacts with p53 in the nucleus and binds to the p53-responsive element of p21/WAF1 promoter. These findings have highlighted a novel role for NUAK1 in LKB1-related signaling pathways; NUAK1 can regulate cell proliferation and exert tumor suppression through direct interaction with p53.

[1]  N. Navaratnam,et al.  Regulation of ploidy and senescence by the AMPK‐related kinase NUAK1 , 2010, The EMBO journal.

[2]  Daniel St Johnston,et al.  A role for Drosophila LKB1 in anterior–posterior axis formation and epithelial polarity , 2003, Nature.

[3]  H. Esumi,et al.  Regulation of caspase-6 and FLIP by the AMPK family member ARK5 , 2004, Oncogene.

[4]  H. Esumi,et al.  Involvement of Transforming Growth Factor-β1 Signaling in Hypoxia-induced Tolerance to Glucose Starvation* , 2005, Journal of Biological Chemistry.

[5]  K. Myburgh,et al.  The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis , 2007, Experimental physiology.

[6]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[7]  M. Kaminishi,et al.  Strong association of ARK5 with tumor invasion and metastasis. , 2004, Journal of experimental & clinical cancer research : CR.

[8]  L. Cantley,et al.  The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. , 2001, Molecular cell.

[9]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Kaminishi,et al.  ARK5 expression in colorectal cancer and its implications for tumor progression. , 2004, The American journal of pathology.

[11]  H. Esumi,et al.  Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein* , 2003, The Journal of Biological Chemistry.

[12]  T. Mäkelä,et al.  Growth suppression by Lkb 1 is mediated by a G 1 cell cycle arrest , 1999 .

[13]  H. Esumi,et al.  ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation , 2003, Oncogene.

[14]  Ettore Appella,et al.  ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation* , 2002, The Journal of Biological Chemistry.

[15]  Russell G. Jones,et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.

[16]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[17]  H. Esumi,et al.  ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling , 2004, Molecular and Cellular Biology.

[18]  Wei Gu,et al.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. , 2003, Current opinion in cell biology.

[19]  John M Sedivy,et al.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.

[20]  M. Kaminishi,et al.  Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. , 2001, Biochemical and biophysical research communications.

[21]  A. Dopazo,et al.  Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway. , 2003, Cancer research.

[22]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[23]  J. Nezu,et al.  Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. , 1998, Nature genetics.

[24]  S. Berger,et al.  LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. , 2006, Cancer research.

[25]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[26]  D. Woods,et al.  Regulation of p53 function. , 2001, Experimental cell research.

[27]  D. Beach,et al.  Polycomb CBX7 has a unifying role in cellular lifespan , 2004, Nature Cell Biology.

[28]  H. Esumi,et al.  NDR2 Acts as the Upstream Kinase of ARK5 during Insulin-like Growth Factor-1 Signaling* , 2006, Journal of Biological Chemistry.

[29]  J. Manfredi,et al.  Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. , 1998, Genes & development.

[30]  G. Sapkota,et al.  Identification and characterization of four novel phosphorylation sites (Ser 31 , Ser 325 , Thr 336 and Thr 366 ) on LKB1/STK11, the protein kinase mutated in Peutz–Jeghers cancer syndrome , 2022 .

[31]  Kei Sakamoto,et al.  Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction , 2005, The EMBO journal.